A limited number of cases of narcolepsy have been reported, mainly in Sweden and Finland, in the context of vaccination against influenza A/H1N1 with the Pandemrix vaccine. No cases have been observed in Belgium. The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMEA) will review all available data to determine if there is a causal link between vaccination with Pandemrix and the cases of narcolepsy reported.
The new edition of the electronic newsletter "VIG-NEWS" of the Federal Agency for Medicines and Health Products (FAMHP) is now available. The VIG-NEWS is a selection of recent news concerning pharmacovigilance from different sources.